Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects
The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V 1 receptor stimulation. However, a possible antidiuretic effect by V 2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. T...
Saved in:
Published in | American journal of physiology. Renal physiology Vol. 295; no. 5; pp. F1295 - F1300 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
01.11.2008
|
Subjects | |
Online Access | Get full text |
ISSN | 1931-857X 1522-1466 |
DOI | 10.1152/ajprenal.90407.2008 |
Cover
Abstract | The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V
1
receptor stimulation. However, a possible antidiuretic effect by V
2
receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V
2
receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C[Formula: see text]), urine osmolality (U
osm
), and fractional distal water excretion (DFeH
2
O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73–214 ng/mmol creatinine, P = 0.001]. C[Formula: see text] decreased 1.05 ml/min (from 0.17 to −0.89 ml/min, P = 0.001), and DFeH
2
O decreased 37% (19 vs. 12; 95% CI 2–11, P = 0.01). U
osm
increased by 27% (93 mosmol/kgH
2
O, 95% CI 23–164 mosmol/kgH
2
O, P = 0.02). Plasma sodium decreased 1.1 mmol/l ( P < 0.01). An increase in AQP2 excretion and a decrease in C[Formula: see text] and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V
2
receptor effect). |
---|---|
AbstractList | The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V
1
receptor stimulation. However, a possible antidiuretic effect by V
2
receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V
2
receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C[Formula: see text]), urine osmolality (U
osm
), and fractional distal water excretion (DFeH
2
O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73–214 ng/mmol creatinine, P = 0.001]. C[Formula: see text] decreased 1.05 ml/min (from 0.17 to −0.89 ml/min, P = 0.001), and DFeH
2
O decreased 37% (19 vs. 12; 95% CI 2–11, P = 0.01). U
osm
increased by 27% (93 mosmol/kgH
2
O, 95% CI 23–164 mosmol/kgH
2
O, P = 0.02). Plasma sodium decreased 1.1 mmol/l ( P < 0.01). An increase in AQP2 excretion and a decrease in C[Formula: see text] and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V
2
receptor effect). The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V1 receptor stimulation. However, a possible antidiuretic effect by V2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V2 receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C(H2O)), urine osmolality (Uosm), and fractional distal water excretion (DFeH2O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73-214 ng/mmol creatinine, P = 0.001]. C(H2O) decreased 1.05 ml/min (from 0.17 to -0.89 ml/min, P = 0.001), and DFeH2O decreased 37% (19 vs. 12; 95% CI 2-11, P = 0.01). Uosm increased by 27% (93 mosmol/kgH2O, 95% CI 23-164 mosmol/kgH2O, P = 0.02). Plasma sodium decreased 1.1 mmol/l (P < 0.01). An increase in AQP2 excretion and a decrease in C(H2O) and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V2 receptor effect). The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V... receptor stimulation. However, a possible antidiuretic effect by V... receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V... receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (...), urine osmolality (...), and fractional distal water excretion (DFeH...O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73-214 ng/mmol creatinine, P = 0.001]. ... decreased 1.05 ml/min (from 0.17 to -0.89 ml/min, P = 0.001), and DFeH...O decreased 37% (19 vs. 12; 95% CI 2-11, P = 0.01). ... increased by 27% (93 mosmol/kgH...O, 95% CI 23-164 mosmol/kgH...O, P = 0.02). Plasma sodium decreased 1.1 mmol/l (P < 0.01). An increase in AQP2 excretion and a decrease in C and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V... receptor effect). (ProQuest: ... denotes formulae/symbols omitted.) The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V1 receptor stimulation. However, a possible antidiuretic effect by V2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V2 receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C(H2O)), urine osmolality (Uosm), and fractional distal water excretion (DFeH2O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73-214 ng/mmol creatinine, P = 0.001]. C(H2O) decreased 1.05 ml/min (from 0.17 to -0.89 ml/min, P = 0.001), and DFeH2O decreased 37% (19 vs. 12; 95% CI 2-11, P = 0.01). Uosm increased by 27% (93 mosmol/kgH2O, 95% CI 23-164 mosmol/kgH2O, P = 0.02). Plasma sodium decreased 1.1 mmol/l (P < 0.01). An increase in AQP2 excretion and a decrease in C(H2O) and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V2 receptor effect).The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V1 receptor stimulation. However, a possible antidiuretic effect by V2 receptor stimulation has never been ruled out. Twenty-two patients with ascites, including seven with refractory ascites, were included. The subjects were studied during a 400 ml/h oral water load before and after infusion of 2 mg of terlipressin (18 patients) or placebo infusion (4 patients). Effects on the V2 receptors were assessed by evaluating aquaporin (AQP)2 excretion, free water clearance (C(H2O)), urine osmolality (Uosm), and fractional distal water excretion (DFeH2O). After terlipressin the excretion of AQP2 increased by 89% [144 ng/mmol creatinine, 95% confidence interval (CI) 73-214 ng/mmol creatinine, P = 0.001]. C(H2O) decreased 1.05 ml/min (from 0.17 to -0.89 ml/min, P = 0.001), and DFeH2O decreased 37% (19 vs. 12; 95% CI 2-11, P = 0.01). Uosm increased by 27% (93 mosmol/kgH2O, 95% CI 23-164 mosmol/kgH2O, P = 0.02). Plasma sodium decreased 1.1 mmol/l (P < 0.01). An increase in AQP2 excretion and a decrease in C(H2O) and distal water excretion after terlipressin despite water loading is a clear indication of activation of the antidiuretic system (V2 receptor effect). |
Author | Pedersen, Erling Bjerregaard Holstein-Rathlou, Niels-Henrik Møller, Søren Krag, Aleksander Bendtsen, Flemming |
Author_xml | – sequence: 1 givenname: Aleksander surname: Krag fullname: Krag, Aleksander – sequence: 2 givenname: Flemming surname: Bendtsen fullname: Bendtsen, Flemming – sequence: 3 givenname: Erling Bjerregaard surname: Pedersen fullname: Pedersen, Erling Bjerregaard – sequence: 4 givenname: Niels-Henrik surname: Holstein-Rathlou fullname: Holstein-Rathlou, Niels-Henrik – sequence: 5 givenname: Søren surname: Møller fullname: Møller, Søren |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18753292$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9LxDAQxYMo6q5-AkGKB29dk7RJG28i_oMFERS8hTSdYJY2XZNU8Nubta4HD55mhvm9d3hvhnbd4AChE4IXhDB6oVZrD051C4FLXC0oxvUOOkwfmpOS8920i4LkNateD9AshBXGmBBK9tEBqStWUEEP0dONMaBjyAaTRfCdTZ4hWJcNLotvkKn3UXmIVmfhM0ToLzP4sC04DRuFctG2dpwAmJyO0J5RXYDjnzlHL7c3z9f3-fLx7uH6apnrktKYG1I1mrRC1aUGSuu2ErgBXgrKmpZpzhnWhDWqacp0Co4ZBVMLYZQwQjdVMUfnk-_aD-8jhCh7GzR0nXIwjEFyUbGyrHkCz_6Aq2H0KbggaYEJJpyxBJ3-QGPTQyvX3vbKf8ptUgkQE6D9EIIHI7WNKtrBRa9sJwmWm1bkthX53YrctJK0xR_tr_0_qi-JaJN7 |
CitedBy_id | crossref_primary_10_1177_2050640618781205 crossref_primary_10_1177_030006051204000512 crossref_primary_10_1016_j_ijso_2022_100494 crossref_primary_10_1016_j_jhep_2024_02_015 crossref_primary_10_1111_apt_12653 crossref_primary_10_1177_2050640619878996 crossref_primary_10_1177_1756283X09102330 crossref_primary_10_1002_hep_24065 crossref_primary_10_1080_14740338_2020_1734558 crossref_primary_10_1002_hep_23893 crossref_primary_10_1016_j_biopha_2023_115116 crossref_primary_10_2147_JEP_S416673 crossref_primary_10_1007_s10072_015_2250_x crossref_primary_10_1002_14651858_CD013123_pub2 crossref_primary_10_3390_ijms23063068 crossref_primary_10_1177_0976500X231175220 crossref_primary_10_1111_imj_12121 crossref_primary_10_1111_jgh_14009 crossref_primary_10_4199_C00085ED1V01Y201305ISP039 crossref_primary_10_1016_j_phrs_2016_08_027 crossref_primary_10_1038_ajg_2016_168 crossref_primary_10_1155_2017_7610374 crossref_primary_10_1080_00365520902912555 crossref_primary_10_3109_00365513_2010_537369 crossref_primary_10_1002_hep_24095 crossref_primary_10_1186_2193_1801_2_519 crossref_primary_10_1136_bmj_m2687 crossref_primary_10_1016_j_crphar_2023_100163 crossref_primary_10_1080_00365521_2020_1744709 crossref_primary_10_1007_s12325_008_0118_7 crossref_primary_10_1097_MCG_0000000000000217 crossref_primary_10_3904_kjm_2014_87_3_323 crossref_primary_10_1038_nrneph_2013_22 crossref_primary_10_14712_23362936_2016_7 crossref_primary_10_1177_17562848221098253 crossref_primary_10_3109_00365521_2010_510576 crossref_primary_10_3390_metabo15020072 crossref_primary_10_3748_wjg_v20_i42_15499 crossref_primary_10_7759_cureus_64576 crossref_primary_10_3109_00365521_2015_1021709 crossref_primary_10_1111_jcpt_13031 crossref_primary_10_1111_jgh_13641 |
Cites_doi | 10.1677/joe.0.0850237 10.1113/jphysiol.1987.sp016745 10.1681/ASN.V891357 10.1152/physrev.00024.2001 10.1152/physrev.00053.2006 10.1152/ajprenal.2001.280.5.F860 10.1007/BF00543482 10.1002/hep.21094 10.1097/00042737-200202000-00009 10.1053/j.gastro.2008.02.024 10.1006/bbrc.1994.2150 10.1056/NEJM199506083322303 10.1002/hep.21414 10.1002/hep.21901 10.1053/j.gastro.2008.02.014 10.1097/00000542-200609000-00026 10.1074/jbc.274.45.32248 10.1016/S0168-8278(00)80158-0 10.1053/jhep.2002.35819 10.1016/S0168-8278(96)80118-8 10.1016/S0168-8278(97)80456-4 10.1002/hep.1840400410 |
ContentType | Journal Article |
Copyright | Copyright American Physiological Society Nov 2008 |
Copyright_xml | – notice: Copyright American Physiological Society Nov 2008 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1152/ajprenal.90407.2008 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1466 |
EndPage | F1300 |
ExternalDocumentID | 1594468241 18753292 10_1152_ajprenal_90407_2008 |
Genre | Research Support, Non-U.S. Gov't Controlled Clinical Trial Journal Article |
GroupedDBID | --- 23M 2WC 39C 4.4 53G 5GY 5VS 6J9 8M5 AAFWJ AAYXX ACPRK ADBBV AENEX AFFNX ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BTFSW C1A CITATION E3Z EBS EJD EMOBN F5P GX1 H13 ITBOX KQ8 OK1 P2P PQQKQ RAP RHI RPL RPRKH TR2 W8F WOQ XSW YSK CGR CUY CVF ECM EIF NPM K9. 7X8 |
ID | FETCH-LOGICAL-c422t-f17bc1d9a84ce228d790be64925bd5c6650c15babb4d5c96052ef899fa9f9cb73 |
ISSN | 1931-857X |
IngestDate | Thu Jul 10 18:44:14 EDT 2025 Mon Jun 30 08:06:48 EDT 2025 Mon Jul 21 06:07:54 EDT 2025 Tue Jul 01 03:46:14 EDT 2025 Thu Apr 24 22:52:13 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c422t-f17bc1d9a84ce228d790be64925bd5c6650c15babb4d5c96052ef899fa9f9cb73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
PMID | 18753292 |
PQID | 230101655 |
PQPubID | 48265 |
ParticipantIDs | proquest_miscellaneous_69754486 proquest_journals_230101655 pubmed_primary_18753292 crossref_citationtrail_10_1152_ajprenal_90407_2008 crossref_primary_10_1152_ajprenal_90407_2008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-11-01 |
PublicationDateYYYYMMDD | 2008-11-01 |
PublicationDate_xml | – month: 11 year: 2008 text: 2008-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda |
PublicationTitle | American journal of physiology. Renal physiology |
PublicationTitleAlternate | Am J Physiol Renal Physiol |
PublicationYear | 2008 |
Publisher | American Physiological Society |
Publisher_xml | – name: American Physiological Society |
References | R21 R20 R23 R22 R25 R24 R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R12 R11 R14 R13 R16 R15 R18 R17 R19 |
References_xml | – ident: R3 doi: 10.1677/joe.0.0850237 – ident: R7 – ident: R10 doi: 10.1113/jphysiol.1987.sp016745 – ident: R21 doi: 10.1681/ASN.V891357 – ident: R16 doi: 10.1152/physrev.00024.2001 – ident: R2 doi: 10.1152/physrev.00053.2006 – ident: R20 doi: 10.1152/ajprenal.2001.280.5.F860 – ident: R19 doi: 10.1007/BF00543482 – ident: R15 doi: 10.1002/hep.21094 – ident: R5 doi: 10.1097/00042737-200202000-00009 – ident: R12 doi: 10.1053/j.gastro.2008.02.024 – ident: R6 doi: 10.1006/bbrc.1994.2150 – ident: R8 doi: 10.1056/NEJM199506083322303 – ident: R1 doi: 10.1002/hep.21414 – ident: R22 – ident: R9 doi: 10.1002/hep.21901 – ident: R23 doi: 10.1053/j.gastro.2008.02.014 – ident: R24 doi: 10.1097/00000542-200609000-00026 – ident: R17 doi: 10.1074/jbc.274.45.32248 – ident: R25 doi: 10.1016/S0168-8278(00)80158-0 – ident: R18 doi: 10.1053/jhep.2002.35819 – ident: R13 doi: 10.1016/S0168-8278(96)80118-8 – ident: R4 doi: 10.1016/S0168-8278(97)80456-4 – ident: R11 – ident: R14 doi: 10.1002/hep.1840400410 |
SSID | ssj0001121 |
Score | 2.1202226 |
Snippet | The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V
1
receptor stimulation. However, a possible antidiuretic effect by V... The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V1 receptor stimulation. However, a possible antidiuretic effect by V2... The vasopressin analog terlipressin is believed to cause vasoconstriction selectively by V... receptor stimulation. However, a possible antidiuretic effect by... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | F1295 |
SubjectTerms | Adolescent Adult Aged Antidiuretic Agents - pharmacology Aquaporin 2 - urine Arginine Vasopressin - blood Blood Pressure - drug effects Blood Pressure - physiology Creatinine - urine Cyclic AMP - urine Drinking - drug effects Drinking - physiology Drugs Female Hepatorenal Syndrome - drug therapy Hepatorenal Syndrome - metabolism Hormones Humans Kidney - drug effects Kidney - physiology Lithium - urine Lypressin - analogs & derivatives Lypressin - pharmacology Lypressin - therapeutic use Male Middle Aged Osmolar Concentration Receptors, Vasopressin - agonists Sodium - blood Studies T cell receptors Urine Urine - chemistry Vasoconstrictor Agents - pharmacology Water - metabolism Water-Electrolyte Balance - drug effects Water-Electrolyte Balance - physiology Young Adult |
Title | Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18753292 https://www.proquest.com/docview/230101655 https://www.proquest.com/docview/69754486 |
Volume | 295 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1522-1466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001121 issn: 1931-857X databaseCode: KQ8 dateStart: 19971001 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1522-1466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001121 issn: 1931-857X databaseCode: KQ8 dateStart: 19980101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1522-1466 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001121 issn: 1931-857X databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuCFoeS3n4gHqBlMYbxwm3gnZVQVso2pX2FtmOU23LJu1ucoC_wR9m7EweFeV5ibJOHK88n8cznhchL1LN05Hh3DNCCi8ACd-LVGh9pkDBDeAudU40R8fhwSx4P-fzweB7z2upKtWu_nZtXMn_UBXagK42SvYfKNt-FBrgHugLV6AwXP-KxuPOGcM6Zi5qp9YcDQAv5WUlXZAi5mt2VXiwiqiz_-flIl1U9Svo2NEXVltrTi-9hDsJcUfxu0Aa29i1tMx7JU8xeOZ87aJnWqXf5GmJZz6AmOWy2Tgdc7Y-1XgetHJR8m_PzGplTiVG_mMIxdoW6PQ-WzeQoqrRDBu8Z8MtFudXTjEiDOfrGG888r2Ii3mfM7O6_iZCkPf47MTHZz_vANxmlJVnNiMoaC8xMCnhXGa7Da8x8h9_TCazw8NkOp5Pdy4uPVuKzJrssS7LDXKTiTC0ZTE-nHQp6EFA9WtXhfoPYyorGPf1NaNeFXd-ocM4WWZ6l9xBJYTu14i6RwYm3yRb-7ksi-VXukM_tSTdJLeO0Ptii5wg3miR0T7eaJFTwBtt8UZrvL2hDdpsjz7aKKLtPplNxtN3Bx6W5PB0wFjpZb5Q2k9jGQXaMAYrOd5TJrQZLlXKdQjyvva5kkoF8BO0Y85MBip9JuMs1kqMHpCNvMjNI0KZjoQwsL0ZJkFrMEqLIIizUMUmzNJIDAlrZi7RmK_elk35kji9lbOkme7ETbcrqDokr9pOF3W6lt-_vt2QJMGltE5AKXdBfnxInrdPgelaS5rMTVGtkzC2eSOjcEge1nTsBrP6P4vZ4z_23Sa3u4XwhGyUq8o8BQG3VM8c4H4AeXiu8A |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+terlipressin+on+the+aquaretic+system%3A+evidence+of+antidiuretic+effects&rft.jtitle=American+journal+of+physiology.+Renal+physiology&rft.au=Krag%2C+Aleksander&rft.au=Bendtsen%2C+Flemming&rft.au=Pedersen%2C+Erling+Bjerregaard&rft.au=Holstein-Rathlou%2C+Niels-Henrik&rft.date=2008-11-01&rft.issn=1931-857X&rft.volume=295&rft.issue=5&rft.spage=F1295&rft_id=info:doi/10.1152%2Fajprenal.90407.2008&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-857X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-857X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-857X&client=summon |